These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7122329

  • 1. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.
    Diamond DA, Berry SJ, Umbricht C, Jewett HJ, Coffey DS.
    Prostate; 1982; 3(4):321-32. PubMed ID: 7122329
    [Abstract] [Full Text] [Related]

  • 2. Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer.
    Epstein JI, Berry SJ, Eggleston JC.
    Cancer; 1984 Oct 15; 54(8):1666-71. PubMed ID: 6478405
    [Abstract] [Full Text] [Related]

  • 3. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.
    Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS.
    J Urol; 1982 Oct 15; 128(4):729-34. PubMed ID: 7143594
    [Abstract] [Full Text] [Related]

  • 4. Correlation of prognosis to nuclear roundness and to flow cytometric light scatter.
    Mohler JL, Partin AW, Coffey DS.
    Anal Quant Cytol Histol; 1987 May 15; 9(2):156-64. PubMed ID: 3300686
    [Abstract] [Full Text] [Related]

  • 5. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.
    Mohler JL, Figlesthaler WM, Zhang XZ, Partin AW, Maygarden SJ.
    Cancer; 1994 Dec 01; 74(11):2996-3001. PubMed ID: 7954263
    [Abstract] [Full Text] [Related]

  • 6. Toward objective prognostic grading of prostatic carcinoma using image analysis.
    Irinopoulou T, Rigaut JP, Benson MC.
    Anal Quant Cytol Histol; 1993 Oct 01; 15(5):341-4. PubMed ID: 8259975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system.
    Mohler JL, Partin AW, Lohr WD, Coffey DS.
    J Urol; 1988 May 01; 139(5):1080-4. PubMed ID: 3361653
    [Abstract] [Full Text] [Related]

  • 10. Nuclear roundness factor and local failure from definitive radiation therapy for prostatic carcinoma.
    Shaeffer J, Tegeler JA, Kuban DA, Philput CB, el-Mahdi AM.
    Int J Radiat Oncol Biol Phys; 1992 May 01; 24(3):431-4. PubMed ID: 1399727
    [Abstract] [Full Text] [Related]

  • 11. Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma.
    Tardif CP, Partin AW, Qaqish B, Epstein JP, Mohler JL.
    Anal Quant Cytol Histol; 1992 Dec 01; 14(6):474-82. PubMed ID: 1292446
    [Abstract] [Full Text] [Related]

  • 12. Nuclear shape and prognosis following orchiectomy in stage D2 prostate cancer.
    Miller J, Horsfall DJ, Skinner JM, Rao DM, Leong AS, Marshall VR.
    Prostate; 1994 Jun 01; 24(6):306-12. PubMed ID: 7516069
    [Abstract] [Full Text] [Related]

  • 13. Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison.
    Mohler JL, Metts JC, Zhang XZ, Maygarden SJ.
    Anal Quant Cytol Histol; 1994 Dec 01; 16(6):415-20. PubMed ID: 7710616
    [Abstract] [Full Text] [Related]

  • 14. Nuclear roundness factor: a quantitative approach to grading in prostatic carcinoma, reliability of needle biopsy tissue, and the effect of tumor stage on usefulness.
    Clark TD, Askin FB, Bagnell CR.
    Prostate; 1987 Dec 01; 10(3):199-206. PubMed ID: 3588411
    [Abstract] [Full Text] [Related]

  • 15. Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.
    Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI.
    Cancer; 1992 Jul 01; 70(1):161-8. PubMed ID: 1606538
    [Abstract] [Full Text] [Related]

  • 16. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
    Veltri RW, Miller MC, Mangold LA, O'Dowd GJ, Epstein JI, Partin AW.
    J Urol; 2002 Jul 01; 168(1):100-4. PubMed ID: 12050500
    [Abstract] [Full Text] [Related]

  • 17. Nuclear morphometry for prediction of metastatic potential in early squamous cell carcinoma of the floor of the mouth.
    Briggs RJ, Pienta KJ, Hruban RH, Richtsmeier WJ.
    Arch Otolaryngol Head Neck Surg; 1992 May 01; 118(5):531-3. PubMed ID: 1571129
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of nuclear roundness as a tool for prostatic carcinoma grading].
    López A, Vilches J, Alvarez-Ossorio J, Aparicio J, Ronco A, Castiñeiras J.
    Actas Urol Esp; 1992 Sep 01; 16(8):620-6. PubMed ID: 1462810
    [Abstract] [Full Text] [Related]

  • 19. Semiautomated nuclear shape analysis of prostatic carcinoma and benign prostatic hyperplasia.
    Kim D, Charlton JD, Coggins JM, Mohler JL.
    Anal Quant Cytol Histol; 1994 Dec 01; 16(6):400-14. PubMed ID: 7536003
    [Abstract] [Full Text] [Related]

  • 20. Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma.
    Ikeguchi M, Sakatani T, Endo K, Makino M, Kaibara N.
    Cancer; 1999 Nov 15; 86(10):1944-51. PubMed ID: 10570417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.